مقایسهٔ روشها
روشهای انتخابی خود را کنار هم مرور کنید؛ ردیفهای متفاوت برجسته شدهاند.
| آزمون فاگرستروم برای وابستگی به نیکوتین× | پرسشنامه سلامت بیمار-۲× | |
|---|---|---|
| حوزه | خدمات سلامت | خدمات سلامت |
| خانواده | Process / pipeline | Process / pipeline |
| سال پیدایش≠ | 1991 | 2003 |
| پدیدآور≠ | Karl O. Fagerstrom | Kurt Kroenke, Robert L. Spitzer, and Janet B. Williams |
| نوع≠ | Six-item nicotine dependence screening | Two-item depression screening instrument |
| منبع بنیادین≠ | Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction, 86(9), 1119-1127. DOI ↗ | Kroenke, K., Spitzer, R. L., & Williams, J. B. (2003). The Patient Health Questionnaire-2: validity of a two-item depression screener. Medical Care, 41(11), 1284-1292. DOI ↗ |
| نامهای دیگر | FTND, Fagerstrom Test | PHQ-2, Patient Health Questionnaire |
| مرتبط | 3 | 3 |
| خلاصه≠ | The Fagerström Test for Nicotine Dependence (FTND) is a brief, validated self-report instrument originally developed by Fagerstrom in 1978 and revised by Heatherton and colleagues in 1991 to quantify the severity of nicotine dependence in cigarette smokers. The FTND comprises six items assessing morning cigarette use, daily cigarette consumption, and the subjective difficulty of abstaining from smoking. It is the most widely used measure of nicotine dependence in smoking cessation research and clinical practice. | The Patient Health Questionnaire-2 (PHQ-2) is an ultra-brief, validated two-item screening instrument developed by Kroenke and colleagues in 2003 to identify major depression in primary care and medical populations. The PHQ-2 assesses the two cardinal symptoms of depression (depressed mood and anhedonia) over the past two weeks using a 0-3 frequency scale. It is the shortest validated depression screening tool enabling routine use in time-constrained clinical settings. |
| ScholarGateمجموعهداده ↗ |
|
|